<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">farmaec</journal-id><journal-title-group><journal-title xml:lang="en">FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology</journal-title><trans-title-group xml:lang="ru"><trans-title>ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2070-4909</issn><issn pub-type="epub">2070-4933</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2070-4909/farmakoekonomika.2022.132</article-id><article-id custom-type="elpub" pub-id-type="custom">farmaec-662</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ ПУБЛИКАЦИИ</subject></subj-group></article-categories><title-group><article-title>Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system</article-title><trans-title-group xml:lang="ru"><trans-title>Организация здравоохранения в сфере реабилитации пациенток с онкологическими заболеваниями репродуктивной системы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Блинов</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Blinov</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., руководитель по научным и медицинским вопросам, ул. Садовая-Триумфальная, д. 4/10, Москва 127006;</p><p>преподаватель кафедры неврологии, психиатрии и наркологии, ул. 2-я Брестская, д. 5, стр. 1-1а, Москва 123056</p></bio><bio xml:lang="en"><p>MD, PhD, MBA, Head of Medical and Scientific Affairs, 4/10 Sadovaya-Triumfalnaya Str., Moscow 127006;</p><p>Faculty Member, Chair of Neurology, Psychiatry and Narcology, 5 bldg 1-1a 2nd Brestskaya Str., Moscow 123056</p></bio><email xlink:type="simple">blinov2010@googlemail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7456-2386</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Солопова</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Solopova</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры акушерства и гинекологии Клинического института детского здоровья им. Н.Ф. Филатова,</p><p>ул. Трубецкая, д. 8/2, Москва 119048</p></bio><bio xml:lang="en"><p>Dr. Med. Sc., Professor, Chair of Obstetrics and Gynecology, Filatov Clinical Institute of Children's Health,</p><p>8/2 Trubetskaya Str., Moscow 119991</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плутницкий</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Plutnitskiy</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, заместитель министра здравоохранения Российской Федерации, директор Департамента проектной деятельности Минздрава России, Рахмановский пер., д. 3, Москва 127994;</p><p>заведующий кафедрой общественного здоровья и здравоохранения с курсом медико-социальной экспертизы, ул. Живописная, д. 46,стр. 8, Москва 123098</p></bio><bio xml:lang="en"><p> Dr. Med. Sc., Professor, Deputy Minister of Health of the Russian Federation, Director of the Department of Project Activities, 3 Rakhmanovskiy Aly, Moscow 127994;</p><p>Chief of Chair of Public Health and Healthcare with a Course of Medical and Social Expertise, 46 bldg 8 Zhivopisnaya Str., Moscow 123098</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ампилогова</surname><given-names>Д. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Ampilogova</surname><given-names>D. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>клинический ординатор кафедры акушерства и гинекологии Института клинической медицины им. Н.В. Склифосовского,</p><p>ул. Трубецкая, д. 8/2, Москва 119048</p></bio><bio xml:lang="en"><p> Clinical Resident, Chair of Obstetrics and Gynecology, Sklifosovsky Institute of Clinical Medicine, </p><p>8/2 Trubetskaya Str., Moscow 119991</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5083-6581</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Санджиева</surname><given-names>Л. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Sandzhieva</surname><given-names>L. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры акушерства и гинекологии Клинического института детского здоровья им. Н.Ф. Филатова,</p><p>ул. Трубецкая, д. 8/2, Москва 119048</p></bio><bio xml:lang="en"><p>Postgraduate, Chair of Obstetrics and Gynecology, Filatov Clinical Institute of Children's Health,</p><p>8/2 Trubetskaya Str., Moscow 119991</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корабельников</surname><given-names>Д. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Korabel’nikov</surname><given-names>D. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., профессор кафедры внутренних болезней с курсами семейной медицины, функциональной диагностики, инфекционных болезней, ректор,</p><p>ул. 2-я Брестская, д. 5, стр. 1-1а, Москва 123056</p></bio><bio xml:lang="en"><p>MD, PhD, Professor, Chair of Internal Diseses with Courses of Family Medicine, Functional Diagnostics, Infectious Diseases, Rector, </p><p>5 bldg 1-1a 2nd Brestskaya Str., Moscow 123056</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петренко</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrenko</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>студентка 6-го курса Международной школы «Медицина будущего»,</p><p>ул. Трубецкая, д. 8/2, Москва 119048</p></bio><bio xml:lang="en"><p>6th Year Student, </p><p>8/2 Trubetskaya Str., Moscow 119991</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Институт Превентивной и Социальной Медицины;&#13;
Автономная некоммерческая организация дополнительного профессионального образования «Московский медико-социальный институт им. Ф.П. Гааза»<country>Россия</country></aff><aff xml:lang="en">Institute for Preventive and Social Medicine;&#13;
Moscow Haass Medical Social Institute<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Федеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский университет)<country>Россия</country></aff><aff xml:lang="en">Sechenov University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">Министерство здравоохранения Российской Федерации;&#13;
 Медико-биологический университет инноваций и непрерывного образования федерального государственного бюджетного учреждения «Государственный научный центр Российской Федерации – Федеральный медицинский биофизический центр им. А.И. Бурназяна» Федерального медико-биологического агентства России<country>Россия</country></aff><aff xml:lang="en">Ministry of Health of the Russian Federation;&#13;
Medico-Biological University of Innovation and Continuing Education, State Scientific Center of the Russian Federation – Burnazyan Federal Medical Biophysical Center, Federal Medical and Biological Agency of Russia<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru">Автономная некоммерческая организация дополнительного профессионального образования «Московский медико-социальный институт им. Ф.П. Гааза»<country>Россия</country></aff><aff xml:lang="en">Moscow Haass Medical Social Institute<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>15</day><month>04</month><year>2022</year></pub-date><volume>15</volume><issue>1</issue><fpage>119</fpage><lpage>130</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Blinov D.V., Solopova A.G., Plutnitskiy A.N., Ampilogova D.M., Sandzhieva L.N., Korabel’nikov D.I., Petrenko D.A., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Блинов Д.В., Солопова А.Г., Плутницкий А.Н., Ампилогова Д.М., Санджиева Л.Н., Корабельников Д.И., Петренко Д.А.</copyright-holder><copyright-holder xml:lang="en">Blinov D.V., Solopova A.G., Plutnitskiy A.N., Ampilogova D.M., Sandzhieva L.N., Korabel’nikov D.I., Petrenko D.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacoeconomics.ru/jour/article/view/662">https://www.pharmacoeconomics.ru/jour/article/view/662</self-uri><abstract><p>During the past decades, the prevalence of cancer diseases of female reproductive system has been constantly growing. The issue is especially acute in reproductive-age women because of earlier oncological pathology onset. Morpho-functional disorders and aggressive methods of anti-tumor therapy significantly affect the patients’ quality of life, psychological well-being, emotional stability, and family relationship, which leads to a limitation of physiological and social possibilities. Rehabilitation programs for oncological patients target to prevent unwanted sequela of the disease, its therapy, and relapses. Pre-rehabilitation plays a special role. It includes psychological and specialized medical care for the patient during the period from the disease verification to the start of therapy. Timely rehabilitation measures reduce the rate of repeated hospitalizations for side effects of chemotherapy, radiotherapy complications, antitumor therapy, and radical surgical interventions. Rehabilitation as a part of standard therapeutic strategy can reduce pharmacoeconomical burden for the health care system. However, further clinical and pharmacoeconomic studies are required for the implementation of rehabilitation at the level of the health care system. </p></abstract><trans-abstract xml:lang="ru"><p>В последние десятилетия растет заболеваемость злокачественными новообразованиями женской половой системы. Особенно актуальным это становится у женщин репродуктивного возраста вследствие «омоложения» опухолевой патологии. Морфофункциональные нарушения и агрессивные методы противоопухолевой терапии оказывают сильнейшее влияние на качество жизни, психологическое благополучие, эмоциональную стабильность, взаимоотношения в семье, приводя к ограничению физиологических и социальных возможностей. Реабилитационные программы для онкогинекологических больных направлены на предотвращение нежелательных последствий самого заболевания, его лечения и рецидивов. Особую роль играет «пререабилитация», включающая оказание необходимой психологической и специализированной медицинской помощи пациентке в период от момента постановки диагноза до начала терапии. Своевременное осуществление мероприятий по реабилитации позволяет снизить число повторных госпитализаций, связанных с побочными явлениями химиотерапии, осложнениями от радиотерапии, противоопухолевого лечения и радикальных хирургических вмешательств. Реабилитация как часть стандартной лечебной тактики способна уменьшить фармакоэкономический ущерб для системы здравоохранения. Однако для внедрения реабилитации на уровне системы здравоохранения требуются дальнейшие клинические и фармакоэкономические исследования. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>онкогинекологические заболевания</kwd><kwd>репродуктивный возраст</kwd><kwd>«пререабилитация»</kwd><kwd>реабилитация</kwd><kwd>качество жизни</kwd><kwd>психосоциальная сфера</kwd><kwd>адаптация</kwd><kwd>социальная значимость</kwd><kwd>система здравоохранения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cancer diseases</kwd><kwd>reproductive age</kwd><kwd>pre-rehabilitation</kwd><kwd>rehabilitation</kwd><kwd>quality of life</kwd><kwd>psychological sphere</kwd><kwd>adaptation</kwd><kwd>social significance</kwd><kwd>health care system</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H., Ferlay J., Siegel R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71 (3): 209–49. https://doi.org/10.3322/caac.21660.</mixed-citation><mixed-citation xml:lang="en">Sung H., Ferlay J., Siegel R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71 (3): 209–49. https://doi.org/10.3322/caac.21660.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021; 18 (10): 663–72. https://doi.org/10.1038/s41571-021-00514-z.</mixed-citation><mixed-citation xml:lang="en">Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021; 18 (10): 663–72. https://doi.org/10.1038/s41571-021-00514-z.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Власина А.Ю., Идрисова Л.Э., Солопова А.Г. и др. Реабилитация онкогинекологических больных после противоопухолевой терапии: пути решения. Акушерство, гинекология и репродукция. 2020; 14 (1): 44–55. https://doi.org/10.17749/2313-7347.2020.14.1.44-55.</mixed-citation><mixed-citation xml:lang="en">Vlasina A.V., Idrisova L.E., Solopova A.G., et al. Rehabilitation of oncogynecological patients after antitumor therapy: ways of solution. Obstetrics, Gynecology and Reproduction. 2020; 14 (1): 44–55 (in Russ.). https://doi.org/10.17749/2313-7347.2020.14.1.44-55.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Старинский В.В., Петрова Г.В. (ред.) Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2019: 250 c. URL: https://oncology-association.ru/wp-content/uploads/2020/09/2018.pdf (дата обращения 03.02.2022).</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinskiy V.V., Petrova G.V. (Eds.) Malignant neoplasms in Russia in 2018 (morbidity and mortality). Мoscow; 2019: 250 pp. Available at: https://oncology-association.ru/wpcontent/uploads/2020/09/2018.pdf (in Russ.) (accessed 03.02.2022).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Идрисова Л.Э., Макацария А.Д. и др. Мультидисциплинарный подход к медицинской реабилитации онкогинекологических больных. Акушерство, гинекология и репродукция. 2017; 11 (4): 57–67. https://doi.org/10.17749/2313-7347.2017.11.4.057-067.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Idrisova L.E., Makatsariya A.D., et al. Multidisciplinary approach to medical rehabilitation of oncogynecologic patients. Obstetrics, Gynecology and Reproduction. 2017; 11 (4): 57–67 (in Russ.). https://doi.org/10.17749/2313-7347.2017.11.4.057-067.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Stucki G., Bickenbach J., Gutenbrunner C., Melvin J. Rehabilitation: the health strategy of the 21st century. J Rehabil Med. 2018; 50 (4): 309–16. https://doi.org/10.2340/16501977-2200.</mixed-citation><mixed-citation xml:lang="en">Stucki G., Bickenbach J., Gutenbrunner C., Melvin J. Rehabilitation: the health strategy of the 21st century. J Rehabil Med. 2018; 50 (4): 309–16. https://doi.org/10.2340/16501977-2200.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Табакман Ю.Ю., Идрисова Л.Э., Сдвижков А.М. Реабилитация онкогинекологических больных. Взгляд на проблему. Акушерство, гинекология и репродукция. 2015; 9 (4): 46–54. https://doi.org/10.17749/2070-4968.2015.9.4.046-054.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Tabakman Y.Y., Idrisova L.E., Sdvizhkov A.M. Rehabilitation of oncogynecologic patients. View of a problem. Obstetrics, Gynecology and Reproduction. 2015; 9 (4): 46–54 (in Russ.). https://doi.org/10.17749/2070-4968.2015.9.4.046-054.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rehabilitation 2030: a call for action. February 6–7, 2017. Executive Boardroom, WHO Headquarters. Meeting Report. URL: https://www.who.int/disabilities/care/Rehab2030MeetingReport_plain_text_version.pdf (дата обращения 03.02.2022).</mixed-citation><mixed-citation xml:lang="en">Rehabilitation 2030: a call for action. February 6–7, 2017. Executive Boardroom, WHO Headquarters. Meeting Report. Available at: https://www.who.int/disabilities/care/Rehab2030MeetingReport_plain_text_ version.pdf (in Russ.) (accessed 03.02.2022).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hoenig H., Nusbaum N., Brummel-Smith K. Geriatric rehabilitation: state of the art. J Am Geriatri Soc. 1997; 45 (11): 1371–81. https://doi.org/10.1111/j.1532-5415.1997.tb02939.x.</mixed-citation><mixed-citation xml:lang="en">Hoenig H., Nusbaum N., Brummel-Smith K. Geriatric rehabilitation: state of the art. J Am Geriatri Soc. 1997; 45 (11): 1371–81. https://doi.org/10.1111/j.1532-5415.1997.tb02939.x.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Saotome T., Klein L., Faux S. Cancer rehabilitation: a barometer for survival? Support Care Cancer. 2015; 23 (10): 3033–41. https://doi.org/10.1007/s00520-015-2673-1.</mixed-citation><mixed-citation xml:lang="en">Saotome T., Klein L., Faux S. Cancer rehabilitation: a barometer for survival? Support Care Cancer. 2015; 23 (10): 3033–41. https://doi.org/10.1007/s00520-015-2673-1.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Anwar S.L., Adistyawan G., Wulaningsih W., et al. Rehabilitation for cancer survivors: how we can reduce the healthcare service inequality in low- and middle-income countries. Am J Phys Med Rehabil. 2018; 97 (10): 764–71. https://doi.org/10.1097/PHM.0000000000000982.</mixed-citation><mixed-citation xml:lang="en">Anwar S.L., Adistyawan G., Wulaningsih W., et al. Rehabilitation for cancer survivors: how we can reduce the healthcare service inequality in low- and middle-income countries. Am J Phys Med Rehabil. 2018; 97 (10): 764–71. https://doi.org/10.1097/PHM.0000000000000982.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Miralpeix E., Mancebo G., Gayete S., et al. Role and impact of multimodal prehabilitation for gynecologic oncology patients in an Enhanced Recovery After Surgery (ERAS) program. Int J Gynecol Cancer. 2019; 29 (8): 1235–43. https://doi.org/10.1136/ijgc-2019-000597.</mixed-citation><mixed-citation xml:lang="en">Miralpeix E., Mancebo G., Gayete S., et al. Role and impact of multimodal prehabilitation for gynecologic oncology patients in an Enhanced Recovery After Surgery (ERAS) program. Int J Gynecol Cancer. 2019; 29 (8): 1235–43. https://doi.org/10.1136/ijgc-2019-000597.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Vonk Noordegraaf A., Anema J.R., van Mechelen W., et al. A personalised eHealth programme reduces the duration until return to work after gynaecological surgery: results of a multicentre randomised trial. BJOG. 2014; 121 (9): 1127–35. https://doi.org/10.1111/1471-0528.12661.</mixed-citation><mixed-citation xml:lang="en">Vonk Noordegraaf A., Anema J.R., van Mechelen W., et al. A personalised eHealth programme reduces the duration until return to work after gynaecological surgery: results of a multicentre randomised trial. BJOG. 2014; 121 (9): 1127–35. https://doi.org/10.1111/1471-0528.12661.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hawkes A.L., Quinn M., Gebski V., et al. Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial. Contemp Clin Trials. 2014; 39 (1): 14–21. https://doi.org/10.1016/j.cct.2014.06.014.</mixed-citation><mixed-citation xml:lang="en">Hawkes A.L., Quinn M., Gebski V., et al. Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial. Contemp Clin Trials. 2014; 39 (1): 14–21. https://doi.org/10.1016/j.cct.2014.06.014.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Falcicchio C., Di Lallo D., Fabi A., et al. Use of rehabilitation pathways in women with breast cancer in the first 12 months of the disease: a retrospective study. BMC Cancer. 2021; 21 (1): 311. https://doi.org/10.1186/s12885-021-07927-0.</mixed-citation><mixed-citation xml:lang="en">Falcicchio C., Di Lallo D., Fabi A., et al. Use of rehabilitation pathways in women with breast cancer in the first 12 months of the disease: a retrospective study. BMC Cancer. 2021; 21 (1): 311. https://doi.org/10.1186/s12885-021-07927-0.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sun Y., Shigaki C.L., Armer J.M. Return to work among breast cancer survivors: a literature review. Support Care Cancer. 2017; 25 (3): 709–18. https://doi.org/10.1007/s00520-016-3446-1.</mixed-citation><mixed-citation xml:lang="en">Sun Y., Shigaki C.L., Armer J.M. Return to work among breast cancer survivors: a literature review. Support Care Cancer. 2017; 25 (3): 709–18. https://doi.org/10.1007/s00520-016-3446-1.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Dholakia J., Cohn D.E., Straughn J.M., Dilley S.E. Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis. J Gynecol Oncol. 2021; 32 (6): e92. https://doi.org/10.3802/jgo.2021.32.e92.</mixed-citation><mixed-citation xml:lang="en">Dholakia J., Cohn D.E., Straughn J.M., Dilley S.E. Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis. J Gynecol Oncol. 2021; 32 (6): e92. https://doi.org/10.3802/jgo.2021.32.e92.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">May A.M., Bosch M.J., Velthuis M.J., et al. Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study. BMJ Open. 2017; 7 (3): e012187. https://doi.org/10.1136/bmjopen-2016-012187.</mixed-citation><mixed-citation xml:lang="en">May A.M., Bosch M.J., Velthuis M.J., et al. Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study. BMJ Open. 2017; 7 (3): e012187. https://doi.org/10.1136/bmjopen-2016-012187.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Gordon L.G., Eakin E.G., Spence R.R., et al. Cost-effectiveness analysis from a randomized controlled trial of tailored exercise prescription for women with breast cancer with 8-year follow-up. Int J Environ Res Public Health. 2020; 17 (22): 8608. https://doi.org/10.3390/ijerph17228608.</mixed-citation><mixed-citation xml:lang="en">Gordon L.G., Eakin E.G., Spence R.R., et al. Cost-effectiveness analysis from a randomized controlled trial of tailored exercise prescription for women with breast cancer with 8-year follow-up. Int J Environ Res Public Health. 2020; 17 (22): 8608. https://doi.org/10.3390/ijerph17228608.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Thorsen L., Gjerset G.M., Loge J.H., et al. Cancer patients' needs for rehabilitation services. Acta Oncol. 2011; 50 (2): 212–22. https://doi.org/10.3109/0284186X.2010.531050.</mixed-citation><mixed-citation xml:lang="en">Thorsen L., Gjerset G.M., Loge J.H., et al. Cancer patients' needs for rehabilitation services. Acta Oncol. 2011; 50 (2): 212–22. https://doi.org/10.3109/0284186X.2010.531050.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Butow P.N., Price M.A., Bell M.L., et al. Caring for women with ovarian cancer in the last year of life: a longitudinal study of caregiver quality of life, distress and unmet needs. Gynecol Oncol. 2014; 132 (3): 690–7. https://doi.org/10.1016/j.ygyno.2014.01.002.</mixed-citation><mixed-citation xml:lang="en">Butow P.N., Price M.A., Bell M.L., et al. Caring for women with ovarian cancer in the last year of life: a longitudinal study of caregiver quality of life, distress and unmet needs. Gynecol Oncol. 2014; 132 (3): 690–7. https://doi.org/10.1016/j.ygyno.2014.01.002.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Holm L.V., Hansen D.G., Kragstrup J., et al. Influence of comorbidity on cancer patients' rehabilitation needs, participation in rehabilitation activities and unmet needs: a population-based cohort study. Support Care Cancer. 2014; 22 (8): 2095–105. https://doi.org/10.1007/s00520-014-2188-1.</mixed-citation><mixed-citation xml:lang="en">Holm L.V., Hansen D.G., Kragstrup J., et al. Influence of comorbidity on cancer patients' rehabilitation needs, participation in rehabilitation activities and unmet needs: a population-based cohort study. Support Care Cancer. 2014; 22 (8): 2095–105. https://doi.org/10.1007/s00520-014-2188-1.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Seland M., Skrede K., Lindemann K., et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand. 2022; 101 (3): 313–22. https://doi.org/10.1111/aogs.14310.</mixed-citation><mixed-citation xml:lang="en">Seland M., Skrede K., Lindemann K., et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand. 2022; 101 (3): 313–22. https://doi.org/10.1111/aogs.14310.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Блинов Д.В., Акарачкова Е.С., Ампилогова Д.М. и др. Депрессия у женщин в менопаузе: организация междисциплинарного подхода в лечении и перспективы реабилитации. Акушерство, гинекология и репродукция. 2021; 15 (6): 738–54. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.280.</mixed-citation><mixed-citation xml:lang="en">Blinov D.V., Akarachkova E.S., Ampilogova D.M., et al. Depression in postmenopause: interdisciplinary approach in management and perspectives for rehabilitation. Obstetrics, Gynecology and Reproduction. 2021; 15 (6): 738–54 (in Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.280.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Almont T., Bujan L., Joachim C., et al. Collaborative digital platform France – Cuba: oncorehabilitation in reproductive and sexual health. BMC Med Educ. 2021; 21 (1): 337. https://doi.org/10.1186/s12909-021-02774-w.</mixed-citation><mixed-citation xml:lang="en">Almont T., Bujan L., Joachim C., et al. Collaborative digital platform France – Cuba: oncorehabilitation in reproductive and sexual health. BMC Med Educ. 2021; 21 (1): 337. https://doi.org/10.1186/s12909-021-02774-w.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
